SofWave Medical Ltd.

Tel Aviv Stock Exchange SOFW.TA

SofWave Medical Ltd. Operating Cash Flow for the year ending December 31, 2023: USD -6.31 M

SofWave Medical Ltd. Operating Cash Flow is USD -6.31 M for the year ending December 31, 2023, a 41.03% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • SofWave Medical Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD -10.69 M, a -409.97% change year over year.
  • SofWave Medical Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD -2.10 M, a 56.34% change year over year.
  • SofWave Medical Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD -4.80 M, a -62.48% change year over year.
  • SofWave Medical Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD -2.96 M.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
Loading...
SV Wall Street
Tel Aviv Stock Exchange: SOFW.TA

SofWave Medical Ltd.

CEO Mr. Louis Scafuri
IPO Date May 18, 2021
Location Israel
Headquarters Hatavor 0
Employees 117
Sector Healthcare
Industries
Description

Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.

StockViz Staff

February 5, 2025

Any question? Send us an email